Luca Casettari
Overview
Explore the profile of Luca Casettari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1042
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perinelli D, Verboni M, Tiboni M, Doutch J, Pisani M, Domenici F, et al.
Langmuir
. 2025 Mar;
PMID: 40051256
-Acyl amino acids are biodegradable anionic amphiphilic molecules made up of linear fatty acids as hydrophobic tails and amino acids as polar heads, which are promising for their applicability in...
2.
Al-Jamal W, Reboredo C, Abdi U, Curci P, Qadadeh R, Alotaibi H, et al.
Int J Pharm
. 2024 Nov;
668:124963.
PMID: 39557180
Indocyanine green (ICG) J-aggregates (IJA) are a unique form of aggregation that exhibits superior properties to monomeric ICG. Despite their higher photoacoustic (PA) signals for imaging and heating stability during...
3.
Eugster R, Orsi M, Buttitta G, Serafini N, Tiboni M, Casettari L, et al.
J Control Release
. 2024 Nov;
376:1025-1038.
PMID: 39489466
Drug delivery systems efficiently and safely administer therapeutic agents to specific body sites. Liposomes, spherical vesicles made of phospholipid bilayers, have become a powerful tool in this field, especially with...
4.
Mihyar R, Shalmani A, Wildt V, Sheybanifard M, Wang A, May J, et al.
J Control Release
. 2024 Sep;
375:614-626.
PMID: 39316925
Controlled manufacturing and long-term stability are key challenges in the development and translation of nanomedicines. This is exemplified by the mRNA-nanoparticle vaccines against COVID-19, which require (ultra-)cold temperatures for storage...
5.
Fratter A, Cignarella A, Ramaschi G, Papetti A, Pellicorio V, Milanese C, et al.
Eur J Pharm Sci
. 2024 Sep;
203:106912.
PMID: 39303769
In recent years, nutraceuticals have emerged as a promising strategy for maintaining health and represent a high-growth market in Italy and across Europe. However, the lack of strict regulations regarding...
6.
Ongoren B, Kara A, Casettari L, Tiboni M, Lalatsa A, Sanz-Perez A, et al.
Int J Pharm
. 2024 Jul;
663:124536.
PMID: 39074648
Vesicants are chemical warfare agents (CWAs) capable of causing severe skin damage and systemic toxicity. Melatonin, known for its anti-inflammatory and antioxidant properties, can mitigate the effects of these agents....
7.
Maurizii G, Valentini L, Sotgiu G, Zamboni R, Tonetti C, Vineis C, et al.
Int J Biol Macromol
. 2024 Jul;
275(Pt 2):133722.
PMID: 38977053
The valorization of discarded wool from dairy sheep breeding is a challenging issue. The most proposed strategies lie in the processing of keratin extracted from wool without reducing the molecular...
8.
Biagiotti S, Canonico B, Tiboni M, Abbas F, Perla E, Montanari M, et al.
Sci Rep
. 2024 Jun;
14(1):14610.
PMID: 38918594
Extracellular vesicles (EVs) are promising natural nanocarriers for the delivery of therapeutic agents. As with any other kind of cell, red blood cells (RBCs) produce a limited number of EVs...
9.
Fontana F, Molinaro G, Moroni S, Pallozzi G, Ferreira M, Pareja Tello R, et al.
Adv Healthc Mater
. 2024 Mar;
13(15):e2302074.
PMID: 38499190
Atherosclerosis still represents a major driver of cardiovascular diseases worldwide. Together with accumulation of lipids in the plaque, inflammation is recognized as one of the key players in the formation...
10.
Arduino I, Di Fonte R, Tiboni M, Porcelli L, Serrati S, Fondaj D, et al.
Int J Pharm
. 2023 Dec;
650:123697.
PMID: 38081557
Optimizing current therapies is among next steps in metastatic melanoma (MM) treatment landscape. The innovation of this study is the design of production process by microfluidics of cell membrane (CM)-modified...